GlassScriptPhysician profile
Yazhen Zhong
NPI 1366543696
$1,927.01
in general payments reported to CMS, 2019-2025
16 companies · $445 in 2025
The $445 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $103 · 2022: $473 · 2023: $374 · 2024: $532 · 2025: $445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,351.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $316.72 | 2021-2025 | Reblozyl, Pomalyst, Breyanzi |
| Karyopharm Therapeutics INC. | $284.95 | 2021-2025 | Xpovio |
| Incyte Corporation | $236.24 | 2022-2025 | Monjuvi |
| Janssen Scientific Affairs, LLC | $187.29 | 2023-2025 | Tecvayli, Darzalex, Talvey |
| E.R. Squibb & Sons, L.L.C. | $134.42 | 2022-2025 | Breyanzi |
| Janssen Biotech, INC. | $119.21 | 2022-2024 | Tecvayli, Talvey, Darzalex |
| Lilly USA, LLC | $113.66 | 2024-2025 | Jaypirca |
| Amgen INC. | $103.39 | 2021-2022 | |
| Adc Therapeutics America, INC. | $98.77 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $92.37 | 2022 | |
| Abbvie INC. | $63.40 | 2023-2024 | |
| Btg International INC. | $62.95 | 2024-2025 | Voraxaze |
| Ipsen Biopharmaceuticals, INC | $33.37 | 2024 | Tazverik |
| Genzyme Corporation | $30.54 | 2023 | |
| Beigene USA, INC. | $24.98 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Morphosys, US INC. | $24.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yazhen Zhong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.